Table 2.
Demographics and standard plasma metrics expressed as average ±standard deviation only for samples with glucose cut-off ≤100 mg/dL.
| Control (n = 57) | NAFLD (n = 7) | p Value | |
|---|---|---|---|
| Age (years) | 42.1 | 46 | |
| Male/Female | 16/41 | 1/8 | |
| BMI (kg/m2) | 29.5 ± 7.9 | 32.4 ± 10.5 | 0.3 |
| Albumin (g/dL) | 3.98 ± 0.21 | 3.97 ± 0.32 | 0.92 |
| Bilirubin (mg/dL) | 0.77 ± 0.24 | 0.62 ± 0.16 | 0.07 |
| ALP(U/L) | 94.8 ± 16.1 | 95.8 ± 21.4 | 0.8 |
| ALT (IU/L) | 21.7 ± 5.4 | 29.6 ± 13.3 | 0.002 |
| AST (IU/L) | 21.1 ± 4.5 | 30.0 ± 13.0 | <0.001 |
| BUN (mg/dL) | 14.03 ± 3.66 | 15.0 ± 5.5 | 0.50 |
| Creatinine (mg/dL) | 0.79 ± 0.18 | 0.75 ± 0.26 | 0.55 |
| Glucose (mg/dL) | 85.35 ± 9.38 | 88.88 ± 10.7 | 0.30 |
| HbA1c (%) | 5.45 ± 0.54 | 5.9 ± 0.4 | 0.44 |
| Total chol (mg/dL) | 199.3 ± 48 | 179.6 ± 26.2 | 0.23 |
| HDL-C (mg/dL) | 47 ± 10 | 47 ± 12 | 0.76 |
| TG (mg/dL) | 159 ± 84 | 150 ± 58.1 | 0.90 |
| TG/HDL-C | 3.4 ± 1.7 | 1.9 ± 0.84 | 0.84 |
| TNF-α (pg/mL) | 1.8 ± 1.1 | 3.57 ± 3.01 | 0.01 |
| Leptin (ng/mL) | 24.18 ± 18.6 | 61.68 ± 32.2 | <0.001 |
| HSI | 38.9 ± 8.35 | 41.27 ± 11.36 | 0.45 |